Patheon.

PositionTRIANGLE BRIEFS: DURHAM

Patheon raised $640 million in an initial public offering. The drugmaker sold 17.6 million shares priced at $21 each. Patheon went private in 2014 when it merged with Netherlands-based vitamin-maker...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT